Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 504 articles:
HTML format



Single Articles


    December 2022
  1. BAKER RE, Saad-Roy CM, Park SW, Farrar J, et al
    Long-term benefits of nonpharmaceutical interventions for endemic infections are shaped by respiratory pathogen dynamics.
    Proc Natl Acad Sci U S A. 2022;119:e2208895119.
    PubMed     Abstract available


  2. SMERDON D
    The effect of masks on cognitive performance.
    Proc Natl Acad Sci U S A. 2022;119:e2206528119.
    PubMed     Abstract available


    November 2022
  3. DU Z, Wang L, Shan S, Lam D, et al
    Pandemic fatigue impedes mitigation of COVID-19 in Hong Kong.
    Proc Natl Acad Sci U S A. 2022;119:e2213313119.
    PubMed     Abstract available


  4. JORGENSEN F, Bor A, Rasmussen MS, Lindholt MF, et al
    Pandemic fatigue fueled political discontent during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2201266119.
    PubMed     Abstract available


  5. KAO KS, Gupta A, Zong G, Li C, et al
    Synthetic nanobodies as tools to distinguish IgG Fc glycoforms.
    Proc Natl Acad Sci U S A. 2022;119:e2212658119.
    PubMed     Abstract available


  6. LIU Q, Miao H, Li S, Zhang P, et al
    Anti-PF4 antibodies associated with disease severity in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2213361119.
    PubMed     Abstract available


  7. BOYLE L, Hletko S, Huang J, Lee J, et al
    Selective sweeps in SARS-CoV-2 variant competition.
    Proc Natl Acad Sci U S A. 2022;119:e2213879119.
    PubMed     Abstract available


  8. HE Q, Xie Y
    The moral filter of patriotic prejudice: How Americans view Chinese in the COVID-19 era.
    Proc Natl Acad Sci U S A. 2022;119:e2212183119.
    PubMed     Abstract available


  9. GARRY RF
    The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade.
    Proc Natl Acad Sci U S A. 2022;119:e2214427119.
    PubMed    


  10. SOLOMON MD, Steinman L, Liu VX
    Reply to Fillmore et al.: Additional evidence of non-SARS-CoV-2 coronavirus cross-immunity.
    Proc Natl Acad Sci U S A. 2022;119:e2215620119.
    PubMed    


  11. FILLMORE NR, Szalat RE, La J, Branch-Elliman W, et al
    Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study.
    Proc Natl Acad Sci U S A. 2022;119:e2213783119.
    PubMed    


  12. SCHIFF ND, Brown EN
    Protective down-regulated states in the human brain: A possible lesson from COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2120221119.
    PubMed     Abstract available


  13. MASSENKOFF M, Chalfin A
    Activity-adjusted crime rates show that public safety worsened in 2020.
    Proc Natl Acad Sci U S A. 2022;119:e2208598119.
    PubMed     Abstract available


  14. CONSTANTINO SM, Cooperman AD, Keohane RO, Weber EU, et al
    Personal hardship narrows the partisan gap in COVID-19 and climate change responses.
    Proc Natl Acad Sci U S A. 2022;119:e2120653119.
    PubMed     Abstract available


  15. MCMAHON M, O'Dell G, Tan J, Sarkozy A, et al
    Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
    Proc Natl Acad Sci U S A. 2022;119:e2206333119.
    PubMed     Abstract available


  16. HARRISON NL, Sachs JD
    Reply to Garry: The origin of SARS-CoV-2 remains unresolved.
    Proc Natl Acad Sci U S A. 2022;119:e2215826119.
    PubMed    


  17. ZHANG W, Shi K, Geng Q, Ye G, et al
    Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant.
    Proc Natl Acad Sci U S A. 2022;119:e2206509119.
    PubMed     Abstract available


  18. GODELLAS NE, Cymes GD, Grosman C
    An experimental test of the nicotinic hypothesis of COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2204242119.
    PubMed     Abstract available


  19. ZHANG P, Philippot Q, Ren W, Lei WT, et al
    Genome-wide detection of human variants that disrupt intronic branchpoints.
    Proc Natl Acad Sci U S A. 2022;119:e2211194119.
    PubMed     Abstract available


    October 2022
  20. PISHESHA N, Harmand T, Carpenet C, Liu X, et al
    Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms.
    Proc Natl Acad Sci U S A. 2022;119:e2211065119.
    PubMed     Abstract available


  21. SMIRNOV O, Hsieh PH
    COVID-19, climate change, and the finite pool of worry in 2019 to 2021 Twitter discussions.
    Proc Natl Acad Sci U S A. 2022;119:e2210988119.
    PubMed     Abstract available


  22. WANG X, Rimal S, Tantray I, Geng J, et al
    Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2-encoded Nsp1.
    Proc Natl Acad Sci U S A. 2022;119:e2202322119.
    PubMed     Abstract available


  23. LI L, Chai Y, Peng W, Li D, et al
    Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel.
    Proc Natl Acad Sci U S A. 2022;119:e2210724119.
    PubMed     Abstract available


  24. KEUSCH GT, Amuasi JH, Anderson DE, Daszak P, et al
    Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses.
    Proc Natl Acad Sci U S A. 2022;119:e2202871119.
    PubMed     Abstract available


  25. ROSU ME, Lexmond P, Bestebroer TM, Hauser BM, et al
    Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B/Victoria and B/Yamagata lineages.
    Proc Natl Acad Sci U S A. 2022;119:e2211616119.
    PubMed     Abstract available


  26. ZHANG F, Zang TM, Stevenson EM, Lei X, et al
    Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins.
    Proc Natl Acad Sci U S A. 2022;119:e2209042119.
    PubMed     Abstract available


  27. LU JG, Song LL, Zheng Y, Wang LC, et al
    Masks as a moral symbol: Masks reduce wearers' deviant behavior in China during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2211144119.
    PubMed     Abstract available


  28. YANG L, Constantino SM, Grenfell BT, Weber EU, et al
    Sociocultural determinants of global mask-wearing behavior.
    Proc Natl Acad Sci U S A. 2022;119:e2213525119.
    PubMed     Abstract available


  29. WATSON-PARRIS D, Christensen MW, Laurenson A, Clewley D, et al
    Shipping regulations lead to large reduction in cloud perturbations.
    Proc Natl Acad Sci U S A. 2022;119:e2206885119.
    PubMed     Abstract available


  30. ASCHMANN HE, Riley AR, Chen R, Chen YH, et al
    Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2210941119.
    PubMed     Abstract available


  31. YANG K, Wang C, Kreutzberger AJB, Ojha R, et al
    Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
    Proc Natl Acad Sci U S A. 2022;119:e2210990119.
    PubMed     Abstract available


  32. GARRY RF
    SARS-CoV-2 furin cleavage site was not engineered.
    Proc Natl Acad Sci U S A. 2022;119:e2211107119.
    PubMed    


    September 2022
  33. CHATURVEDI S, Beutler N, Vasen G, Pablo M, et al
    A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters.
    Proc Natl Acad Sci U S A. 2022;119:e2204624119.
    PubMed     Abstract available


  34. MCDERMOTT A
    Kids adopt different ways of coping in wake of the pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2214564119.
    PubMed    


  35. KREUTZBERGER AJB, Sanyal A, Saminathan A, Bloyet LM, et al
    SARS-CoV-2 requires acidic pH to infect cells.
    Proc Natl Acad Sci U S A. 2022;119:e2209514119.
    PubMed     Abstract available


  36. COHEN JE, Davis RA, Samorodnitsky G
    COVID-19 cases and deaths in the United States follow Taylor's law for heavy-tailed distributions with infinite variance.
    Proc Natl Acad Sci U S A. 2022;119:e2209234119.
    PubMed     Abstract available


  37. VAN SOLINGEN C, Cyr Y, Scacalossi KR, de Vries M, et al
    Long noncoding RNA CHROMR regulates antiviral immunity in humans.
    Proc Natl Acad Sci U S A. 2022;119:e2210321119.
    PubMed     Abstract available


  38. MCGRATH ME, Xue Y, Dillen C, Oldfield L, et al
    SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis.
    Proc Natl Acad Sci U S A. 2022;119:e2204717119.
    PubMed     Abstract available


  39. VAN BEEK M, Nussenzweig MC, Chakraborty AK
    Two complementary features of humoral immune memory confer protection against the same or variant antigens.
    Proc Natl Acad Sci U S A. 2022;119:e2205598119.
    PubMed     Abstract available


  40. ENDO A, Uchida M, Liu Y, Atkins KE, et al
    Simulating respiratory disease transmission within and between classrooms to assess pandemic management strategies at schools.
    Proc Natl Acad Sci U S A. 2022;119:e2203019119.
    PubMed     Abstract available


  41. POPLI S, Chakravarty S, Fan S, Glanz A, et al
    IRF3 inhibits nuclear translocation of NF-kappaB to prevent viral inflammation.
    Proc Natl Acad Sci U S A. 2022;119:e2121385119.
    PubMed     Abstract available


  42. AZNAOUROVA M, Schmerer N, Janga H, Zhang Z, et al
    Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2120680119.
    PubMed     Abstract available


  43. CARLEY S, Graff M, Konisky DM, Memmott T, et al
    Behavioral and financial coping strategies among energy-insecure households.
    Proc Natl Acad Sci U S A. 2022;119:e2205356119.
    PubMed     Abstract available


  44. SHAFFER L
    Lots of long COVID treatment leads, but few are proven.
    Proc Natl Acad Sci U S A. 2022;119:e2213524119.
    PubMed    


    August 2022
  45. CARIOU M, Picard L, Gueguen L, Jacquet S, et al
    Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2206610119.
    PubMed     Abstract available


  46. CRUNFLI F, Carregari VC, Veras FP, Silva LS, et al
    Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2200960119.
    PubMed     Abstract available


  47. ABURTO JM, Tilstra AM, Floridi G, Dowd JB, et al
    Significant impacts of the COVID-19 pandemic on race/ethnic differences in US mortality.
    Proc Natl Acad Sci U S A. 2022;119:e2205813119.
    PubMed     Abstract available


  48. LU M, Chamblee M, Zhang Y, Ye C, et al
    SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
    Proc Natl Acad Sci U S A. 2022;119:e2110105119.
    PubMed     Abstract available


  49. CHANDRA S
    Data analysis of viral complementary DNA/RNA sequences for low-frequency intrahost-single nucleotide variants in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2205269119.
    PubMed    


  50. BASHOR L, Gagne RB, Bosco-Lauth A, Bowen RA, et al
    Reply to Chandra: Severe Acute Respiratory Syndrome-Coronavirus-2 variant analysis reveals within-host selection of intra-host single nucleotide variants.
    Proc Natl Acad Sci U S A. 2022;119:e2206919119.
    PubMed    


  51. JOSEPH M, Wu Y, Dannebaum R, Rubelt F, et al
    Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2201541119.
    PubMed     Abstract available


  52. YANG Z, Wu D, Lu S, Qiu Y, et al
    Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2117089119.
    PubMed     Abstract available


  53. XIONG H, Sun H, Wang S, Yuan L, et al
    The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204256119.
    PubMed     Abstract available


  54. MENG F, Yang H, Qu Z, Chen Y, et al
    A Eurasian avian-like H1N1 swine influenza reassortant virus became pathogenic and highly transmissible due to mutations in its PA gene.
    Proc Natl Acad Sci U S A. 2022;119:e2203919119.
    PubMed     Abstract available


  55. CHEN J, Ye Z, Huang C, Qiu M, et al
    Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response.
    Proc Natl Acad Sci U S A. 2022;119:e2207841119.
    PubMed     Abstract available


  56. WANG X, Du Z, James E, Fox SJ, et al
    The effectiveness of COVID-19 testing and contact tracing in a US city.
    Proc Natl Acad Sci U S A. 2022;119:e2200652119.
    PubMed     Abstract available


  57. BANKER M, Miller M, Voichek G, Goor D, et al
    Prosocial nudges and visual indicators increase social distancing, but authoritative nudges do not.
    Proc Natl Acad Sci U S A. 2022;119:e2116156119.
    PubMed     Abstract available


  58. ZHANG Y, Lu M, Mahesh KC, Kim E, et al
    A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2022;119:e2201616119.
    PubMed     Abstract available


  59. IWAMURA C, Hirahara K, Kiuchi M, Ikehara S, et al
    Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.
    Proc Natl Acad Sci U S A. 2022;119:e2203437119.
    PubMed     Abstract available


  60. SOLOMON MD, Escobar GJ, Lu Y, Schlessinger D, et al
    Risk of severe COVID-19 infection among adults with prior exposure to children.
    Proc Natl Acad Sci U S A. 2022;119:e2204141119.
    PubMed     Abstract available


  61. GARCIA-MORO E, Zhang J, Calder LJ, Brown NR, et al
    Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH.
    Proc Natl Acad Sci U S A. 2022;119:e2208011119.
    PubMed     Abstract available


  62. NOONE DP, Dijkstra DJ, van der Klugt TT, van Veelen PA, et al
    PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation.
    Proc Natl Acad Sci U S A. 2022;119:e2208144119.
    PubMed     Abstract available


  63. LI W, Wang Q, Liu Y, Small ML, et al
    A spatiotemporal decay model of human mobility when facing large-scale crises.
    Proc Natl Acad Sci U S A. 2022;119:e2203042119.
    PubMed     Abstract available


  64. VU MN, Lokugamage KG, Plante JA, Scharton D, et al
    QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.
    Proc Natl Acad Sci U S A. 2022;119:e2205690119.
    PubMed     Abstract available


  65. XU Z, Choi JH, Dai DL, Luo J, et al
    SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation.
    Proc Natl Acad Sci U S A. 2022;119:e2204539119.
    PubMed     Abstract available


  66. GUO K, Barrett BS, Morrison JH, Mickens KL, et al
    Interferon resistance of emerging SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2022;119:e2203760119.
    PubMed     Abstract available


  67. KRYMOVA E, Bejar B, Thanou D, Sun T, et al
    Trend estimation and short-term forecasting of COVID-19 cases and deaths worldwide.
    Proc Natl Acad Sci U S A. 2022;119:e2112656119.
    PubMed     Abstract available


  68. GAMBETTA D, Morisi D
    COVID-19 infection induces higher trust in strangers.
    Proc Natl Acad Sci U S A. 2022;119:e2116818119.
    PubMed     Abstract available


  69. LUO G, Zhang J, Lin L, Mignot EJ, et al
    Characterization of T cell receptors reactive to HCRTNH2, pHA273-287, and NP17-31 in control and narcolepsy patients.
    Proc Natl Acad Sci U S A. 2022;119:e2205797119.
    PubMed     Abstract available


  70. MELIN JL, Correll SJ
    Preventing soft skill decay among early-career women in STEM during COVID-19: Evidence from a longitudinal intervention.
    Proc Natl Acad Sci U S A. 2022;119:e2123105119.
    PubMed     Abstract available


  71. SYED AM, Ciling A, Taha TY, Chen IP, et al
    Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.
    Proc Natl Acad Sci U S A. 2022;119:e2200592119.
    PubMed     Abstract available


  72. MIKOLAJEK H, Weckener M, Brotzakis ZF, Huo J, et al
    Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes.
    Proc Natl Acad Sci U S A. 2022;119:e2205412119.
    PubMed     Abstract available


  73. TOWNSEND JP, Hassler HB, Sah P, Galvani AP, et al
    The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204336119.
    PubMed     Abstract available


    July 2022
  74. HUANG S, Fishell G
    In SARS-CoV-2, astrocytes are in it for the long haul.
    Proc Natl Acad Sci U S A. 2022;119:e2209130119.
    PubMed    


  75. MARTNER A, Grauers Wiktorin H, Tornell A, Ringlander J, et al
    Transient and durable T cell reactivity after COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2203659119.
    PubMed     Abstract available


  76. LIU Q, Wang H, Zhang H, Sui L, et al
    The global succinylation of SARS-CoV-2-infected host cells reveals drug targets.
    Proc Natl Acad Sci U S A. 2022;119:e2123065119.
    PubMed     Abstract available


  77. ANDREWS MG, Mukhtar T, Eze UC, Simoneau CR, et al
    Tropism of SARS-CoV-2 for human cortical astrocytes.
    Proc Natl Acad Sci U S A. 2022;119:e2122236119.
    PubMed     Abstract available


  78. YUAN M, Zhu X, He WT, Zhou P, et al
    A broad and potent neutralization epitope in SARS-related coronaviruses.
    Proc Natl Acad Sci U S A. 2022;119:e2205784119.
    PubMed     Abstract available


  79. FISMAN D
    Universal healthcare and the pandemic mortality gap.
    Proc Natl Acad Sci U S A. 2022;119:e2208032119.
    PubMed    


  80. LONDAHL J, Alsved M
    Abrupt decreases in infectivity of SARS-CoV-2 in aerosols.
    Proc Natl Acad Sci U S A. 2022;119:e2208742119.
    PubMed    


  81. RABB N, Bowers J, Glick D, Wilson KH, et al
    The influence of social norms varies with "others" groups: Evidence from COVID-19 vaccination intentions.
    Proc Natl Acad Sci U S A. 2022;119:e2118770119.
    PubMed     Abstract available


  82. MAHAS A, Marsic T, Lopez-Portillo Masson M, Wang Q, et al
    Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2118260119.
    PubMed     Abstract available


  83. BAN DK, Bodily T, Karkisaval AG, Dong Y, et al
    Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor.
    Proc Natl Acad Sci U S A. 2022;119:e2206521119.
    PubMed     Abstract available


  84. KARDAVA L, Rachmaninoff N, Lau WW, Buckner CM, et al
    Early human B cell signatures of the primary antibody response to mRNA vaccination.
    Proc Natl Acad Sci U S A. 2022;119:e2204607119.
    PubMed     Abstract available


  85. BEUCHER G, Blondot ML, Celle A, Pied N, et al
    Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction.
    Proc Natl Acad Sci U S A. 2022;119:e2202370119.
    PubMed     Abstract available


  86. KAPOOR K, Chen T, Tajkhorshid E
    Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors.
    Proc Natl Acad Sci U S A. 2022;119:e2119761119.
    PubMed     Abstract available


  87. IOANNIDIS JPA, Bendavid E, Salholz-Hillel M, Boyack KW, et al
    Massive covidization of research citations and the citation elite.
    Proc Natl Acad Sci U S A. 2022;119:e2204074119.
    PubMed     Abstract available


  88. IOB E, Steptoe A, Zaninotto P
    Mental health, financial, and social outcomes among older adults with probable COVID-19 infection: A longitudinal cohort study.
    Proc Natl Acad Sci U S A. 2022;119:e2200816119.
    PubMed     Abstract available


  89. OSWIN HP, Haddrell AE, Otero-Fernandez M, Mann JFS, et al
    The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment.
    Proc Natl Acad Sci U S A. 2022;119:e2200109119.
    PubMed     Abstract available


  90. HU G, Hamovit N, Croft K, Roberts JD, et al
    Assessing inequities underlying racial disparities of COVID-19 mortality in Louisiana parishes.
    Proc Natl Acad Sci U S A. 2022;119:e2123533119.
    PubMed     Abstract available


    June 2022
  91. ALETA A, Martin-Corral D, Bakker MA, Pastore Y Piontti A, et al
    Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas.
    Proc Natl Acad Sci U S A. 2022;119:e2112182119.
    PubMed     Abstract available


  92. DIEDERICHS M, van Ewijk R, Isphording IE, Pestel N, et al
    Schools under mandatory testing can mitigate the spread of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2201724119.
    PubMed     Abstract available


  93. HU M, Qiu Z, Bi Z, Tian T, et al
    Photocontrolled crRNA activation enables robust CRISPR-Cas12a diagnostics.
    Proc Natl Acad Sci U S A. 2022;119:e2202034119.
    PubMed     Abstract available


  94. SHEN Y, Courtney JM, Anfinrud P, Bax A, et al
    Hybrid measurement of respiratory aerosol reveals a dominant coarse fraction resulting from speech that remains airborne for minutes.
    Proc Natl Acad Sci U S A. 2022;119:e2203086119.
    PubMed     Abstract available


  95. QIN C, Rao Y, Yuan H, Wang TY, et al
    SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis.
    Proc Natl Acad Sci U S A. 2022;119:e2122897119.
    PubMed     Abstract available


  96. SNYDER M, Alburez-Gutierrez D, Williams I, Zagheni E, et al
    Estimates from 31 countries show the significant impact of COVID-19 excess mortality on the incidence of family bereavement.
    Proc Natl Acad Sci U S A. 2022;119:e2202686119.
    PubMed     Abstract available


  97. ANAHTAR M, Chan LW, Ko H, Rao A, et al
    Host protease activity classifies pneumonia etiology.
    Proc Natl Acad Sci U S A. 2022;119:e2121778119.
    PubMed     Abstract available


  98. GALVANI AP, Parpia AS, Pandey A, Sah P, et al
    Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2200536119.
    PubMed     Abstract available


  99. SIMONETTI B, Daly JL, Simon-Gracia L, Klein K, et al
    ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.
    Proc Natl Acad Sci U S A. 2022;119:e2201980119.
    PubMed     Abstract available


  100. LIMA DE MIRANDA K, Snower DJ
    The societal responses to COVID-19: Evidence from the G7 countries.
    Proc Natl Acad Sci U S A. 2022;119:e2117155119.
    PubMed     Abstract available


  101. AMERICO JL, Cotter CA, Earl PL, Liu R, et al
    Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119:e2202069119.
    PubMed     Abstract available


  102. ENGELBERT BAIN L, Berner-Rodoreda A, McMahon SA, Sarker M, et al
    One lesson of COVID-19: Conduct more health policy trials.
    Proc Natl Acad Sci U S A. 2022;119:e2119887119.
    PubMed    


  103. LEECH G, Rogers-Smith C, Monrad JT, Sandbrink JB, et al
    Mask wearing in community settings reduces SARS-CoV-2 transmission.
    Proc Natl Acad Sci U S A. 2022;119:e2119266119.
    PubMed     Abstract available


    May 2022
  104. HEKMATI A, Luhar M, Krishnamachari B, Mataric M, et al
    Simulating COVID-19 classroom transmission on a university campus.
    Proc Natl Acad Sci U S A. 2022;119:e2116165119.
    PubMed     Abstract available


  105. MUTSCH B, Heiber M, Gratz F, Hain R, et al
    Aerosol particle emission increases exponentially above moderate exercise intensity resulting in superemission during maximal exercise.
    Proc Natl Acad Sci U S A. 2022;119:e2202521119.
    PubMed     Abstract available



  106. A global experiment on motivating social distancing during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2111091119.
    PubMed     Abstract available


  107. ZHU X, Han J, Sun W, Puente-Massaguer E, et al
    Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.
    Proc Natl Acad Sci U S A. 2022;119:e2200821119.
    PubMed     Abstract available


  108. BAXTER-KING R, Brown JR, Enos RD, Naeim A, et al
    How local partisan context conditions prosocial behaviors: Mask wearing during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2116311119.
    PubMed     Abstract available


  109. ZHANG C, Verma A, Feng Y, Melo MCR, et al
    Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119:e2123000119.
    PubMed     Abstract available


  110. MANRY J, Bastard P, Gervais A, Le Voyer T, et al
    The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
    Proc Natl Acad Sci U S A. 2022;119:e2200413119.
    PubMed     Abstract available


  111. COMAR CE, Otter CJ, Pfannenstiel J, Doerger E, et al
    MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.
    Proc Natl Acad Sci U S A. 2022;119:e2123208119.
    PubMed     Abstract available


  112. ELTOBGY MM, Zani A, Kenney AD, Estfanous S, et al
    Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis.
    Proc Natl Acad Sci U S A. 2022;119:e2202012119.
    PubMed     Abstract available


  113. HARRISON NL, Sachs JD
    A call for an independent inquiry into the origin of the SARS-CoV-2 virus.
    Proc Natl Acad Sci U S A. 2022;119:e2202769119.
    PubMed    


  114. KINGSTAD-BAKKE B, Lee W, Chandrasekar SS, Gasper DJ, et al
    Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
    Proc Natl Acad Sci U S A. 2022;119:e2118312119.
    PubMed     Abstract available


  115. TORRES JL, Ozorowski G, Andreano E, Liu H, et al
    Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
    Proc Natl Acad Sci U S A. 2022;119:e2120976119.
    PubMed     Abstract available


  116. SUKHWAL PC, Kankanhalli A
    Determining containment policy impacts on public sentiment during the pandemic using social media data.
    Proc Natl Acad Sci U S A. 2022;119:e2117292119.
    PubMed     Abstract available


  117. SPRECO A, Schon T, Timpka T
    Corruption should be taken into account when considering COVID-19 vaccine allocation.
    Proc Natl Acad Sci U S A. 2022;119:e2122664119.
    PubMed    


  118. DUCH R, Robinson TS, Clarke PM, Roope LSJ, et al
    Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations.
    Proc Natl Acad Sci U S A. 2022;119:e2201847119.
    PubMed    


  119. HONG J, Kwon HJ, Cachau R, Chen CZ, et al
    Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2022;119:e2201433119.
    PubMed     Abstract available


  120. PAIREAU J, Andronico A, Hoze N, Layan M, et al
    An ensemble model based on early predictors to forecast COVID-19 health care demand in France.
    Proc Natl Acad Sci U S A. 2022;119:e2103302119.
    PubMed     Abstract available


  121. LEE YY, Cal-Kayitmazbatir S, Francey LJ, Bahiru MS, et al
    duper is a null mutation of Cryptochrome 1 in Syrian hamsters.
    Proc Natl Acad Sci U S A. 2022;119:e2123560119.
    PubMed     Abstract available


  122. HALL GJ, Sargent TJ
    Three world wars: Fiscal-monetary consequences.
    Proc Natl Acad Sci U S A. 2022;119:e2200349119.
    PubMed     Abstract available


    April 2022
  123. VICENS Q, Kieft JS
    Thoughts on how to think (and talk) about RNA structure.
    Proc Natl Acad Sci U S A. 2022;119:e2112677119.
    PubMed     Abstract available


  124. ZHAO Y, Zhu Y, Liu X, Jin Z, et al
    Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2117142119.
    PubMed     Abstract available


  125. YANG K, Wang C, White KI, Pfuetzner RA, et al
    Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle.
    Proc Natl Acad Sci U S A. 2022;119:e2119467119.
    PubMed     Abstract available


  126. MORRISON CB, Edwards CE, Shaffer KM, Araba KC, et al
    SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13.
    Proc Natl Acad Sci U S A. 2022;119:e2119680119.
    PubMed     Abstract available


  127. CRAMER EY, Ray EL, Lopez VK, Bracher J, et al
    Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States.
    Proc Natl Acad Sci U S A. 2022;119:e2113561119.
    PubMed     Abstract available


  128. ROBINSON PC, Liew DFL, Tanner HL, Grainger JR, et al
    COVID-19 therapeutics: Challenges and directions for the future.
    Proc Natl Acad Sci U S A. 2022;119:e2119893119.
    PubMed     Abstract available


  129. SUN Z, Wang L, Li X, Fan C, et al
    An extended conformation of SARS-CoV-2 main protease reveals allosteric targets.
    Proc Natl Acad Sci U S A. 2022;119:e2120913119.
    PubMed     Abstract available


  130. GARCIA BULLE B, Shen D, Shah D, Hosoi AE, et al
    Public health implications of opening National Football League stadiums during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2114226119.
    PubMed     Abstract available


  131. BAUER MS, Gruber S, Hausch A, Gomes PSFC, et al
    A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.
    Proc Natl Acad Sci U S A. 2022;119:e2114397119.
    PubMed     Abstract available


  132. TEPLENSKY MH, Distler ME, Kusmierz CD, Evangelopoulos M, et al
    Spherical nucleic acids as an infectious disease vaccine platform.
    Proc Natl Acad Sci U S A. 2022;119:e2119093119.
    PubMed     Abstract available


    March 2022
  133. KAVISHNA R, Kang TY, Vacca M, Chua BYL, et al
    A single-shot vaccine approach for the universal influenza A vaccine candidate M2e.
    Proc Natl Acad Sci U S A. 2022;119:e2025607119.
    PubMed     Abstract available


  134. SCHMELZ K, Bowles S
    Opposition to voluntary and mandated COVID-19 vaccination as a dynamic process: Evidence and policy implications of changing beliefs.
    Proc Natl Acad Sci U S A. 2022;119:e2118721119.
    PubMed     Abstract available


  135. PEEPLES L
    Understanding Kids and COVID.
    Proc Natl Acad Sci U S A. 2022;119:e2203753119.
    PubMed    


  136. THOMAS LJ, Huang P, Yin F, Xu J, et al
    Geographical patterns of social cohesion drive disparities in early COVID infection hazard.
    Proc Natl Acad Sci U S A. 2022;119:e2121675119.
    PubMed     Abstract available


  137. LEWNARD JA, Fries LF, Cho I, Chen J, et al
    Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2022;119:e2112410119.
    PubMed     Abstract available


  138. GALBRAITH MD, Kinning KT, Sullivan KD, Araya P, et al
    Specialized interferon action in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  139. SHAN S, Luo S, Yang Z, Hong J, et al
    Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization.
    Proc Natl Acad Sci U S A. 2022;119:e2122954119.
    PubMed     Abstract available


  140. GEHLHAUSEN JR, Little AJ, Ko CJ, Emmenegger M, et al
    Lack of association between pandemic chilblains and SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  141. ZEBERG H
    The major genetic risk factor for severe COVID-19 is associated with protection against HIV.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  142. MOELLER NH, Shi K, Demir O, Belica C, et al
    Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    February 2022
  143. DEVARAJAN P, Vong AM, Castonguay CH, Kugler-Umana O, et al
    Strong influenza-induced TFH generation requires CD4 effectors to recognize antigen locally and receive signals from continuing infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  144. BARMAN TK, Huber VC, Bonin JL, Califano D, et al
    Viral PB1-F2 and host IFN-gamma guide ILC2 and T cell activity during influenza virus infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  145. WIECEK W, Ahuja A, Chaudhuri E, Kremer M, et al
    Testing fractional doses of COVID-19 vaccines.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  146. SCHUHENN J, Meister TL, Todt D, Bracht T, et al
    Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  147. PANDEY P, Al Rumaih Z, Kels MJT, Ng E, et al
    Targeting ectromelia virus and TNF/NF-kappaB or STAT3 signaling for effective treatment of viral pneumonia.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  148. DI SERIO C, Cippa P, Ceschi A, Ferrari P, et al
    Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


  149. FOX SJ, Lachmann M, Tec M, Pasco R, et al
    Real-time pandemic surveillance using hospital admissions and mobility data.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  150. GOLDRICK-RAB S, Coca V, Gill J, Peele M, et al
    Self-reported COVID-19 infection and implications for mental health and food insecurity among American college students.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  151. KUCHIPUDI SV, Surendran-Nair M, Ruden RM, Yon M, et al
    Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  152. SHI Y, Zeida A, Edwards CE, Mallory ML, et al
    Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  153. RINGLANDER J, Fingal J, Kann H, Prakash K, et al
    Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  154. MILDER FJ, Jongeneelen M, Ritschel T, Bouchier P, et al
    Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  155. PANDEY JP
    IgG3 constant region GM (gamma marker) allotypes could influence the neutralizing potency of anti-SARS-CoV-2 monoclonal antibodies.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


  156. MILKMAN KL, Gandhi L, Patel MS, Graci HN, et al
    A 680,000-person megastudy of nudges to encourage vaccination in pharmacies.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  157. PALACIOS J, Fan Y, Yoeli E, Wang J, et al
    Encouraging the resumption of economic activity after COVID-19: Evidence from a large scale-field experiment in China.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  158. DESPRES HW, Mills MG, Shirley DJ, Schmidt MM, et al
    Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  159. BEANS C
    Researchers getting closer to a "universal" flu vaccine.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


    January 2022
  160. ROSENKRANTZ DJ, Vullikanti A, Ravi SS, Stearns RE, et al
    Fundamental limitations on efficiently forecasting certain epidemic measures in network models.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  161. CHANG KC, Hobbs WR, Roberts ME, Steinert-Threlkeld ZC, et al
    COVID-19 increased censorship circumvention and access to sensitive topics in China.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  162. YANG B, Jia Y, Meng Y, Xue Y, et al
    SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  163. RODRIGUEZ-RIVAS J, Croce G, Muscat M, Weigt M, et al
    Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  164. CHOI VK, Shrestha S, Pan X, Gelfand MJ, et al
    When danger strikes: A linguistic tool for tracking America's collective response to threats.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  165. HUYNH E, Olinger A, Woolley D, Kohli RK, et al
    Evidence for a semisolid phase state of aerosols and droplets relevant to the airborne and surface survival of pathogens.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  166. FLORES A, Cole JC, Dickert S, Eom K, et al
    Politicians polarize and experts depolarize public support for COVID-19 management policies across countries.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  167. GANDON S, Lion S
    Targeted vaccination and the speed of SARS-CoV-2 adaptation.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  168. HUPERT N, Marin-Hernandez D, Gao B, Aguas R, et al
    Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  169. AUGENBLICK N, Kolstad J, Obermeyer Z, Wang A, et al
    Pooled testing efficiency increases with test frequency.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  170. FRAZIER PI, Cashore JM, Duan N, Henderson SG, et al
    Modeling for COVID-19 college reopening decisions: Cornell, a case study.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  171. ZENG C, Evans JP, King T, Zheng YM, et al
    SARS-CoV-2 spreads through cell-to-cell transmission.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  172. YU S, Zheng X, Zhou B, Li J, et al
    SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  173. LEON J, Michelson DA, Olejnik J, Chowdhary K, et al
    A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    December 2021
  174. PAWLICA P, Yario TA, White S, Wang J, et al
    SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  175. JAMIESON KH, Romer D, Jamieson PE, Winneg KM, et al
    The role of non-COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  176. CHANDRAN V, Bermudez ML, Koka M, Chandran B, et al
    Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  177. ASTLEY CM, Tuli G, Mc Cord KA, Cohn EL, et al
    Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  178. SALOMON JA, Reinhart A, Bilinski A, Chua EJ, et al
    The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  179. MCDONALD DJ, Bien J, Green A, Hu AJ, et al
    Can auxiliary indicators improve COVID-19 forecasting and hotspot prediction?
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  180. REINHART A, Brooks L, Jahja M, Rumack A, et al
    An open repository of real-time COVID-19 indicators.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  181. NAIR P
    QnAs with Katalin Kariko.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  182. ROSENFELD R, Tibshirani RJ
    Epidemic tracking and forecasting: Lessons learned from a tumultuous year.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  183. LIU X, Luongo C, Matsuoka Y, Park HS, et al
    A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  184. ALVAREZ L, Colom M, Morel JD, Morel JM, et al
    Computing the daily reproduction number of COVID-19 by inverting the renewal equation using a variational technique.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  185. CHEN J, Fan J, Chen Z, Zhang M, et al
    Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  186. WATERLOW NR, van Leeuwen E, Davies NG, Flasche S, et al
    How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  187. BAGHERI G, Thiede B, Hejazi B, Schlenczek O, et al
    An upper bound on one-to-one exposure to infectious human respiratory particles.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  188. KE R, Zitzmann C, Ho DD, Ribeiro RM, et al
    In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  189. BOKEMPER SE, Gerber AS, Omer SB, Huber GA, et al
    Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    November 2021
  190. PENG Y, Wu P, Schartup AT, Zhang Y, et al
    Plastic waste release caused by COVID-19 and its fate in the global ocean.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  191. CHANDLER JC, Bevins SN, Ellis JW, Linder TJ, et al
    SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  192. BANKS MA
    Core Concept: In the wake of COVID-19, decentralized clinical trials move to center stage.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  193. ENDO A, Uchida M, Hayashi N, Liu Y, et al
    Within and between classroom transmission patterns of seasonal influenza among primary school students in Matsumoto city, Japan.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  194. PAN K, Chiu Y, Huang E, Chen M, et al
    Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  195. LAUGHNER JL, Neu JL, Schimel D, Wennberg PO, et al
    Societal shifts due to COVID-19 reveal large-scale complexities and feedbacks between atmospheric chemistry and climate change.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  196. TERRIER C, Chen DL, Sutter M
    COVID-19 within families amplifies the prosociality gap between adolescents of high and low socioeconomic status.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  197. LOPEZ N, Del Debbio L, Baaden M, Praprotnik M, et al
    Lessons learned from urgent computing in Europe: Tackling the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  198. BALISTRERI G, Yamauchi Y, Teesalu T
    A widespread viral entry mechanism: The C-end Rule motif-neuropilin receptor interaction.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  199. PEDERSON T
    A layperson encounter, on the "modified" RNA world.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  200. XIA D, Jin R, Byagathvalli G, Yu H, et al
    An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  201. LEVY R, Zhang P, Bastard P, Dorgham K, et al
    Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  202. SAMET JM, Burke TA, Lakdawala SS, Lowe JJ, et al
    SARS-CoV-2 indoor air transmission is a threat that can be addressed with science.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  203. PISHESHA N, Harmand TJ, Rothlauf PW, Praest P, et al
    A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  204. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reply to Briggs et al.: Genomic integration and expression of SARS-CoV-2 sequences can explain prolonged or recurrent viral RNA detection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  205. BRIGGS E, Ward W, Rey S, Law D, et al
    Assessment of potential SARS-CoV-2 virus integration into human genome reveals no significant impact on RT-qPCR COVID-19 testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  206. SUN L, Kallolimath S, Palt R, Stiasny K, et al
    Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  207. BASHOR L, Gagne RB, Bosco-Lauth AM, Bowen RA, et al
    SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    October 2021
  208. MAHONEY M, Damalanka VC, Tartell MA, Chung DH, et al
    A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  209. RAY D, Le L, Andricioaei I
    Distant residues modulate conformational opening in SARS-CoV-2 spike protein.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  210. LU L, Anderson B, Ha R, D'Agostino A, et al
    A language-matching model to improve equity and efficiency of COVID-19 contact tracing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  211. HUGHES MT, Auwaerter PG, Ehmann MR, Garibaldi BT, et al
    Opinion: The importance of offering vaccine choice in the fight against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  212. POULTER B, Freeborn PH, Jolly WM, Varner JM, et al
    COVID-19 lockdowns drive decline in active fires in southeastern United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  213. URANO E, Okamura T, Ono C, Ueno S, et al
    COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  214. LIU X, Verma A, Garcia G Jr, Ramage H, et al
    Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  215. CHERNOZHUKOV V, Kasahara H, Schrimpf P
    The association of opening K-12 schools with the spread of COVID-19 in the United States: County-level panel data analysis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  216. TEODORESCU K, Plonsky O, Ayal S, Barkan R, et al
    Frequency of enforcement is more important than the severity of punishment in reducing violation behaviors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  217. HENSEN L, Nguyen THO, Rowntree LC, Damelang T, et al
    Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  218. YE C, Chiem K, Park JG, Silvas JA, et al
    Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  219. FISCHER JB, Kobayashi Frisk L, Scholkmann F, Delgado-Mederos R, et al
    Cerebral and systemic physiological effects of wearing face masks in young adults.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  220. WU X, Rapoport TA
    Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  221. ODOR G, Czifra D, Komjathy J, Lovasz L, et al
    Switchover phenomenon induced by epidemic seeding on geometric networks.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  222. VELU C, Iyer S
    Learning from near misses from COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  223. LOURDA M, Dzidic M, Hertwig L, Bergsten H, et al
    High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  224. MCKEOWN B, Poerio GL, Strawson WH, Martinon LM, et al
    The impact of social isolation and changes in work patterns on ongoing thought during the first COVID-19 lockdown in the United Kingdom.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  225. ALGAN Y, Cohen D, Davoine E, Foucault M, et al
    Trust in scientists in times of pandemic: Panel evidence from 12 countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  226. KALLOLIMATH S, Sun L, Palt R, Stiasny K, et al
    Highly active engineered IgG3 antibodies against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    September 2021
  227. GOLDMAN E
    How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  228. ANDERSON DE, Cui J, Ye Q, Huang B, et al
    Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  229. CRONIN CJ, Evans WN
    Excess mortality from COVID and non-COVID causes in minority populations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  230. JIN W, Stokes JM, Eastman RT, Itkin Z, et al
    Deep learning identifies synergistic drug combinations for treating COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  231. MCGEE RS, Homburger JR, Williams HE, Bergstrom CT, et al
    Model-driven mitigation measures for reopening schools during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  232. DIEKMANN O, Othmer HG, Planque R, Bootsma MCJ, et al
    The discrete-time Kermack-McKendrick model: A versatile and computationally attractive framework for modeling epidemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  233. ROSSMANN L, Bagola K, Stephen T, Gerards AL, et al
    Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  234. MELVIN WJ, Audu CO, Davis FM, Sharma SB, et al
    Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  235. KING HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, et al
    Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  236. DALVIE NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, et al
    Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  237. DUCH R, Roope LSJ, Violato M, Fuentes Becerra M, et al
    Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  238. FISMAN DN, Tuite AR
    Asymptomatic infection is the pandemic's dark matter.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  239. GALVAN-PENA S, Leon J, Chowdhary K, Michelson DA, et al
    Profound Treg perturbations correlate with COVID-19 severity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  240. WANG J, Alipour M, Soligo G, Roccon A, et al
    Short-range exposure to airborne virus transmission and current guidelines.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  241. PROTO E, Zhang A
    COVID-19 and mental health of individuals with different personalities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  242. PORTER E, Wood TJ
    The global effectiveness of fact-checking: Evidence from simultaneous experiments in Argentina, Nigeria, South Africa, and the United Kingdom.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  243. CHAMAKURI S, Lu S, Ucisik MN, Bohren KM, et al
    DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M(pro) inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  244. ANDREANO E, Piccini G, Licastro D, Casalino L, et al
    SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  245. KLUVER H, Hartmann F, Humphreys M, Geissler F, et al
    Incentives can spur COVID-19 vaccination uptake.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  246. MIRABELLI C, Wotring JW, Zhang CJ, McCarty SM, et al
    Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  247. MAZEL-SANCHEZ B, Iwaszkiewicz J, Bonifacio JPP, Silva F, et al
    Influenza A viruses balance ER stress with host protein synthesis shutoff.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  248. LI Z, Liu R, Zhan CG, Wang X, et al
    Reply to Behnam and Klein: Potential role of the His-tag in C-terminal His-tagged SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  249. BEHNAM MAM, Klein CD
    Inhibitor potency and assay conditions: A case study on SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  250. HEUVELINE P
    The COVID-19 pandemic adds another 200,000 deaths (50%) to the annual toll of excess mortality in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  251. BROWN RA
    A simple model for control of COVID-19 infections on an urban campus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  252. AASSVE A, Cavalli N, Mencarini L, Plach S, et al
    Early assessment of the relationship between the COVID-19 pandemic and births in high-income countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  253. LU Y, Kaushal N, Huang X, Gaddis SM, et al
    Priming COVID-19 salience increases prejudice and discriminatory intent against Asians and Hispanics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    August 2021
  254. SILVA PJS, Sagastizabal C, Nonato LG, Struchiner CJ, et al
    Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  255. CARTER JG, Orueta Iturbe L, Duprey JHA, Carter IR, et al
    Ultrarapid detection of SARS-CoV-2 RNA using a reverse transcription-free exponential amplification reaction, RTF-EXPAR.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  256. MARANI M, Katul GG, Pan WK, Parolari AJ, et al
    Intensity and frequency of extreme novel epidemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  257. SULLIVAN O, Gershuny J, Sevilla A, Foliano F, et al
    Using time-use diaries to track changing behavior across successive stages of COVID-19 social restrictions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  258. KIM E, Attia Z, Woodfint RM, Zeng C, et al
    Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  259. SAH P, Fitzpatrick MC, Zimmer CF, Abdollahi E, et al
    Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  260. KAUGARS K, Dardick J, de Oliveira AP, Weiss KA, et al
    A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  261. RAMAN G, Peng JC
    Electricity consumption of Singaporean households reveals proactive community response to COVID-19 progression.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  262. GILLES S, Traidl-Hoffmann C, Damialis A
    Reply to Betsch and Sprengholz: Higher SARS-CoV-2 infection numbers related to more airborne pollen, regardless of testing frequency.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  263. BETSCH C, Sprengholz P
    The human factor between airborne pollen concentrations and COVID-19 disease dynamics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  264. AGUILAR E, Roberts NJ, Uluturk I, Kaminski P, et al
    Adaptive staffing can mitigate essential worker disease and absenteeism in an emerging epidemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  265. PAUL BD, Lemle MD, Komaroff AL, Snyder SH, et al
    Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  266. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Response to Parry et al.: Strong evidence for genomic integration of SARS-CoV-2 sequences and expression in patient tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  267. PARRY R, Gifford RJ, Lytras S, Ray SC, et al
    No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  268. AGARWAL R, Dugas M, Ramaprasad J, Luo J, et al
    Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  269. FETZER T, Graeber T
    Measuring the scientific effectiveness of contact tracing: Evidence from a natural experiment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  270. XING X, Xiong Y, Yang R, Wang R, et al
    Predicting the effect of confinement on the COVID-19 spread using machine learning enriched with satellite air pollution observations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  271. ASHWORTH M, Thunstrom L, Cherry TL, Newbold SC, et al
    Emphasize personal health benefits to boost COVID-19 vaccination rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  272. PINK SL, Chu J, Druckman JN, Rand DG, et al
    Elite party cues increase vaccination intentions among Republicans.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  273. BAKER A, Biazzo I, Braunstein A, Catania G, et al
    Epidemic mitigation by statistical inference from contact tracing data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  274. SINCLAIR AH, Hakimi S, Stanley ML, Adcock RA, et al
    Pairing facts with imagined consequences improves pandemic-related risk perception.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  275. BETSCH C, Sprengholz P, Siegers R, Eitze S, et al
    Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  276. RUDIGER S, Konigorski S, Rakowski A, Edelman JA, et al
    Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  277. ARCHIBONG B, Metcalf CJE
    Building toward useful SARS-CoV-2 models in Africa.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  278. IRONS NJ, Raftery AE
    Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  279. HAN X, Xu Y, Fan L, Huang Y, et al
    Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    July 2021
  280. DE LIMA LF, Ferreira AL, Torres MDT, de Araujo WR, et al
    Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  281. STAQUICINI DI, Tang FHF, Markosian C, Yao VJ, et al
    Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  282. JANG WD, Jeon S, Kim S, Lee SY, et al
    Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  283. KERR GH, Goldberg DL, Anenberg SC
    COVID-19 pandemic reveals persistent disparities in nitrogen dioxide pollution.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  284. DAMPALLA CS, Zheng J, Perera KD, Wong LR, et al
    Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  285. WANG Y, Yang C, Song Y, Coleman JR, et al
    Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  286. GOLDSTEIN JR, Cassidy T, Wachter KW
    Reply to Dushoff et al. and Pifarre i Arolas et al.: Age prioritization for COVID-19 vaccination does save lives and years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  287. DUSHOFF J, Colijn C, Earn DJD, Bolker BM, et al
    Transmission dynamics are crucial to COVID-19 vaccination policy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  288. JELLIFFE E, Pangburn P, Pichler S, Ziebarth NR, et al
    Awareness and use of (emergency) sick leave: US employees' unaddressed sick leave needs in a global pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  289. ROCHMAN ND, Wolf YI, Faure G, Mutz P, et al
    Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  290. ZHANG H, Zhu W, Jin Q, Pan F, et al
    Inhalable nanocatchers for SARS-CoV-2 inhibition.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  291. PETERSEN MB, Bor A, Jorgensen F, Lindholt MF, et al
    Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  292. ORNES S
    Science and Culture: The evolving portrait of a virus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  293. TSCHERNE A, Schwarz JH, Rohde C, Kupke A, et al
    Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  294. SSENTONGO P, Fronterre C, Geronimo A, Greybush SJ, et al
    Pan-African evolution of within- and between-country COVID-19 dynamics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  295. IMAI M, Halfmann PJ, Yamayoshi S, Iwatsuki-Horimoto K, et al
    Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  296. SALON D, Conway MW, Capasso da Silva D, Chauhan RS, et al
    The potential stickiness of pandemic-induced behavior changes in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  297. STOHNER J
    Does exhaled aerosol increase with COVID-19 infection correlate with body mass index-years?
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  298. RHINEY K, Guido Z, Knudson C, Avelino J, et al
    Epidemics and the future of coffee production.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  299. SILVERSTEIN NJ, Luban J
    Lessons from a local effort to screen for SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  300. PENG T, Du SY, Son M, Diamond B, et al
    HIF-1alpha is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  301. PERSSON J, Parie JF, Feuerriegel S
    Monitoring the COVID-19 epidemic with nationwide telecommunication data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  302. YANG J, Wen Y, Wang Y, Zhang S, et al
    From COVID-19 to future electrification: Assessing traffic impacts on air quality by a machine-learning model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  303. KLINE D, Li Z, Chu Y, Wakefield J, et al
    Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  304. SARR D, Gingerich AD, Asthiwi NM, Almutairi F, et al
    Dual oxidase 1 promotes antiviral innate immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  305. SENDER R, Bar-On YM, Gleizer S, Bernshtein B, et al
    The total number and mass of SARS-CoV-2 virions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  306. SCHMELZ K, Bowles S
    Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  307. REES CA, Rostad CA, Mantus G, Anderson EJ, et al
    Altered amino acid profile in patients with SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  308. SMITH TP, Flaxman S, Gallinat AS, Kinosian SP, et al
    Temperature and population density influence SARS-CoV-2 transmission in the absence of nonpharmaceutical interventions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  309. HOU X, Gao S, Li Q, Kang Y, et al
    Intracounty modeling of COVID-19 infection with human mobility: Assessing spatial heterogeneity with business traffic, age, and race.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  310. HSU JC, Laurent-Rolle M, Pawlak JB, Wilen CB, et al
    Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  311. SIEGRIST M, Bearth A
    Worldviews, trust, and risk perceptions shape public acceptance of COVID-19 public health measures.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  312. ROCK C, Zenilman J
    Opinion: How to ensure regulations don't stymie much-needed COVID-19 point-of-care testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  313. SATO-KANEKO F, Yao S, Lao FS, Nan J, et al
    Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  314. MCCARTHY KR, Von Holle TA, Sutherland LL, Oguin TH 3rd, et al
    Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  315. ZHANG Y, Chen Y, Li Y, Huang F, et al
    The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  316. LEVER J, Altman RB
    Analyzing the vast coronavirus literature with CoronaCentral.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  317. LU JG, Jin P, English AS
    Collectivism predicts mask use during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  318. ZHAO J, Jaffe A, Li H, Lindenbaum O, et al
    Detection of differentially abundant cell subpopulations in scRNA-seq data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  319. WU Y, Mooring TA, Linz M
    Policy and weather influences on mobility during the early US COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  320. SIA ZR, He X, Zhang A, Ang JC, et al
    A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2021
  321. KANG S, Tanaka T, Inoue H, Ono C, et al
    Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  322. CHENG L, Zhu Z, Wang C, Wang P, et al
    COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  323. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  324. GENG X, Katul GG, Gerges F, Bou-Zeid E, et al
    A kernel-modulated SIR model for Covid-19 contagious spread from county to continent.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  325. DEMORA SL, Merolla JL, Newman B, Zechmeister EJ, et al
    Reducing mask resistance among White evangelical Christians with value-consistent messages.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  326. YANG Q, Saldi TK, Gonzales PK, Lasda E, et al
    Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  327. REINHART E, Chen DL
    Carceral-community epidemiology, structural racism, and COVID-19 disparities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  328. CHUMAKOV K, Avidan MS, Benn CS, Bertozzi SM, et al
    Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  329. MCDERMOTT A
    Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  330. STAMBAUGH A, Parks JW, Stott MA, Meena GG, et al
    Optofluidic multiplex detection of single SARS-CoV-2 and influenza A antigens using a novel bright fluorescent probe assay.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  331. MILKMAN KL, Patel MS, Gandhi L, Graci HN, et al
    A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  332. GREMESE E, Alivernini S, Ferraccioli G
    RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  333. GURRIERI L, Fairbairn CE, Sayette MA, Bosch N, et al
    Alcohol narrows physical distance between strangers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  334. MALONE B, Chen J, Wang Q, Llewellyn E, et al
    Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  335. DONG C, Wang Y, Gonzalez GX, Ma Y, et al
    Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  336. MORSELLI GYSI D, do Valle I, Zitnik M, Ameli A, et al
    Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  337. NI X, Ouyang W, Jeong H, Kim JT, et al
    Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  338. PYMM P, Adair A, Chan LJ, Cooney JP, et al
    Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  339. KRUCZKIEWICZ A, Klopp J, Fisher J, Mason S, et al
    Opinion: Compound risks and complex emergencies require new approaches to preparedness.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  340. HREBIK D, Fuzik T, Gondova M, Smerdova L, et al
    ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  341. CHANDRASEKHAR AG, Goldsmith-Pinkham P, Jackson MO, Thau S, et al
    Interacting regional policies in containing a disease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  342. MAEDA DLNF, Tian D, Yu H, Dar N, et al
    Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  343. SAWATZKI K, Hill NJ, Puryear WB, Foss AD, et al
    Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  344. BAIR E, Stillinger T, Rittger K, Skiles M, et al
    COVID-19 lockdowns show reduced pollution on snow and ice in the Indus River Basin.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  345. SWANK Z, Michielin G, Yip HM, Cohen P, et al
    A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  346. GALEA S
    Understanding why we do what we do during a global pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    April 2021
  347. TKACHENKO AV, Maslov S, Elbanna A, Wong GN, et al
    Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  348. MENA EL, Donahue CJ, Vaites LP, Li J, et al
    ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  349. ENGZELL P, Frey A, Verhagen MD
    Learning loss due to school closures during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  350. BAZANT MZ, Bush JWM
    A guideline to limit indoor airborne transmission of COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  351. YAN Y, Malik AA, Bayham J, Fenichel EP, et al
    Measuring voluntary and policy-induced social distancing behavior during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  352. BUCKNER JH, Chowell G, Springborn MR
    Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  353. PRESTON SH, Vierboom YC
    Excess mortality in the United States in the 21st century.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  354. CASTRO MC, Singer B
    Prioritizing COVID-19 vaccination by age.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  355. KRAUS S, Koch N
    Provisional COVID-19 infrastructure induces large, rapid increases in cycling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  356. RIZZI S, Vaupel JW
    Short-term forecasts of expected deaths.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  357. HE X, Quan S, Xu M, Rodriguez S, et al
    Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  358. BERRY CR, Fowler A, Glazer T, Handel-Meyer S, et al
    Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  359. GRANGE ZL, Goldstein T, Johnson CK, Anthony S, et al
    Ranking the risk of animal-to-human spillover for newly discovered viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  360. SCHEUFELE DA, Hoffman AJ, Neeley L, Reid CM, et al
    Misinformation about science in the public sphere.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  361. KORN L, Bohm R, Betsch C
    Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  362. SNEPPEN K, Nielsen BF, Taylor RJ, Simonsen L, et al
    Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  363. BJERRE-NIELSEN A, Kassarnig V, Lassen DD, Lehmann S, et al
    Task-specific information outperforms surveillance-style big data in predictive analytics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  364. RABB N, Glick D, Houston A, Bowers J, et al
    No evidence that collective-good appeals best promote COVID-related health behaviors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  365. JO WK, Schadenhofer A, Habierski A, Kaiser FK, et al
    Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  366. WEISEL O
    Vaccination as a social contract: The case of COVID-19 and US political partisanship.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  367. HONG B, Bonczak BJ, Gupta A, Thorpe LE, et al
    Exposure density and neighborhood disparities in COVID-19 infection risk.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  368. CONLEY D, Johnson T
    Opinion: Past is future for the era of COVID-19 research in the social sciences.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  369. MENDELS DA, Dortet L, Emeraud C, Oueslati S, et al
    Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  370. LIU Y, Hu G, Wang Y, Ren W, et al
    Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  371. SINGH S, Shaikh M, Hauck K, Miraldo M, et al
    Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  372. LIU R, Americo JL, Cotter CA, Earl PL, et al
    One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  373. LU M, Dravid P, Zhang Y, Trivedi S, et al
    A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  374. DAMIALIS A, Gilles S, Sofiev M, Sofieva V, et al
    Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  375. GIURGE LM, Whillans AV, Yemiscigil A
    A multicountry perspective on gender differences in time use during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  376. JI W, Li X, Chen S, Ren L, et al
    Transmission of SARS-CoV-2 via fomite, especially cold chain, should not be ignored.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  377. SHUMSKY RA, Debo L, Lebeaux RM, Nguyen QP, et al
    Retail store customer flow and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  378. GOLDSTEIN JR, Cassidy T, Wachter KW
    Vaccinating the oldest against COVID-19 saves both the most lives and most years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  379. KIZILCEC RF, Makridis CA, Sadowski KC
    Pandemic response policies' democratizing effects on online learning.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  380. THURNER S, Klimek P, Hanel R
    Reply to Kusmierz and Toyoizumi: A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  381. KAPLAN RM, Milstein A
    Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  382. LI K, Jacob DJ, Liao H, Qiu Y, et al
    Ozone pollution in the North China Plain spreading into the late-winter haze season.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  383. ZEBERG H, Paabo S
    A genomic region associated with protection against severe COVID-19 is inherited from Neandertals.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  384. CLARK SJ, Turner AN
    Monitoring epidemics: Lessons from measuring population prevalence of the coronavirus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  385. BENTON DJ, Wrobel AG, Roustan C, Borg A, et al
    The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  386. VLACHOS J, Hertegard E, B Svaleryd H
    The effects of school closures on SARS-CoV-2 among parents and teachers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  387. GIUNTELLA O, Hyde K, Saccardo S, Sadoff S, et al
    Lifestyle and mental health disruptions during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  388. SUBRAMANIAN R, He Q, Pascual M
    Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  389. NADEAU SA, Vaughan TG, Scire J, Huisman JS, et al
    The origin and early spread of SARS-CoV-2 in Europe.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  390. FREYN AW, Han J, Guthmiller JJ, Bailey MJ, et al
    Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  391. LI Z, Lin Y, Huang YY, Liu R, et al
    Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  392. MA C, Wang J
    Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  393. EDWARDS DA, Ausiello D, Salzman J, Devlin T, et al
    Exhaled aerosol increases with COVID-19 infection, age, and obesity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  394. PERRY BL, Aronson B, Pescosolido BA
    Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  395. FAZIO RH, Ruisch BC, Moore CA, Granados Samayoa JA, et al
    Social distancing decreases an individual's likelihood of contracting COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  396. NEANT N, Lingas G, Le Hingrat Q, Ghosn J, et al
    Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  397. AZIMI P, Keshavarz Z, Cedeno Laurent JG, Stephens B, et al
    Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  398. XIE W, Zhang W
    Reply to Marot et al.: The struggle to comply with social-distancing is multifaceted, as are the ways of mitigating it.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  399. MAROT M, Chevalere J, Spatola N
    Depressed mood, a better predictor of social-distancing compliance and candidate for intervention compared to working memory capacity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  400. TORRATS-ESPINOSA G
    Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  401. KVEDARAITE E, Hertwig L, Sinha I, Ponzetta A, et al
    Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  402. LAPOINTE CP, Grosely R, Johnson AG, Wang J, et al
    Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  403. FINLAY BB, Amato KR, Azad M, Blaser MJ, et al
    The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  404. WITTEMAN HO, Haverfield J, Tannenbaum C
    COVID-19 gender policy changes support female scientists and improve research quality.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  405. SASISEKHARAN V, Pentakota N, Jayaraman A, Tharakaraman K, et al
    Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  406. ANDRASFAY T, Goldman N
    Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  407. YIANNOUTSOS CT, Halverson PK, Menachemi N
    Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  408. BORCHERING RK, Gunning CE, Gokhale DV, Weedop KB, et al
    Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  409. JAN JT, Cheng TR, Juang YP, Ma HH, et al
    Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  410. HOWARD J, Huang A, Li Z, Tufekci Z, et al
    An evidence review of face masks against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  411. MARZIANO V, Guzzetta G, Rondinone BM, Boccuni F, et al
    Retrospective analysis of the Italian exit strategy from COVID-19 lockdown.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  412. BERGER L, Berger N, Bosetti V, Gilboa I, et al
    Rational policymaking during a pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  413. HANNA CC, Ashhurst AS, Quan D, Maxwell JWC, et al
    Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  414. GIGLIO S, Maggiori M, Stroebel J, Utkus S, et al
    The joint dynamics of investor beliefs and trading during the COVID-19 crash.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  415. HOPKINS DJ, Meredith M, Chainani A, Olin N, et al
    Results from a 2020 field experiment encouraging voting by mail.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  416. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
    Vaccinology in the post-COVID-19 era.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  417. VOUTOURI C, Nikmaneshi MR, Hardin CC, Patel AB, et al
    In silico dynamics of COVID-19 phenotypes for optimizing clinical management.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  418. EVENSEN D, Whitmarsh L, Bartie P, Devine-Wright P, et al
    Effect of "finite pool of worry" and COVID-19 on UK climate change perceptions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  419. PARK SW, Sun K, Champredon D, Li M, et al
    Forward-looking serial intervals correctly link epidemic growth to reproduction numbers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  420. BERENBAUM MR
    On COVID-19, cognitive bias, and open access.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  421. CHEN MK, Chevalier JA, Long EF
    Nursing home staff networks and COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  422. CARLETON T, Cornetet J, Huybers P, Meng KC, et al
    Global evidence for ultraviolet radiation decreasing COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  423. CIPPA PE, Cugnata F, Ferrari P, Brombin C, et al
    A data-driven approach to identify risk profiles and protective drugs in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  424. LI R
    Mobility restrictions are more than transient reduction of travel activities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  425. SIMONESCHI D
    Opinion: We need to improve the welfare of life science trainees.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  426. LIU K, Tan S, Niu S, Wang J, et al
    Cross-species recognition of SARS-CoV-2 to bat ACE2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  427. MUELLER JT, McConnell K, Burow PB, Pofahl K, et al
    Impacts of the COVID-19 pandemic on rural America.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  428. JUNG H, Albarracin D
    Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  429. SCHMELZ K
    Enforcement may crowd out voluntary support for COVID-19 policies, especially where trust in government is weak and in a liberal society.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  430. SCHLOSSER F, Maier BF, Jack O, Hinrichs D, et al
    COVID-19 lockdown induces disease-mitigating structural changes in mobility networks.
    Proc Natl Acad Sci U S A. 2020;117:32883-32890.
    PubMed     Abstract available


  431. CENTOLA D
    Considering network interventions.
    Proc Natl Acad Sci U S A. 2020;117:32833-32835.
    PubMed    


  432. MITZE T, Kosfeld R, Rode J, Walde K, et al
    Face masks considerably reduce COVID-19 cases in Germany.
    Proc Natl Acad Sci U S A. 2020;117:32293-32301.
    PubMed     Abstract available


  433. WEITZ JS, Park SW, Eksin C, Dushoff J, et al
    Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations.
    Proc Natl Acad Sci U S A. 2020;117:32764-32771.
    PubMed     Abstract available


  434. ZANG R, Case JB, Yutuc E, Ma X, et al
    Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
    Proc Natl Acad Sci U S A. 2020;117:32105-32113.
    PubMed     Abstract available


  435. TUPPER P, Boury H, Yerlanov M, Colijn C, et al
    Event-specific interventions to minimize COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:32038-32045.
    PubMed     Abstract available


  436. TAYLOR CA, Boulos C, Almond D
    Livestock plants and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:31706-31715.
    PubMed     Abstract available


  437. WANG Y, Mao Q, Zhou X
    Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
    Proc Natl Acad Sci U S A. 2020;117:30896-30897.
    PubMed    


  438. ZENG HL, Dichio V, Rodriguez Horta E, Thorell K, et al
    Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
    Proc Natl Acad Sci U S A. 2020;117:31519-31526.
    PubMed     Abstract available


  439. XU X, Han M, Li T, Sun W, et al
    Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.
    Proc Natl Acad Sci U S A. 2020;117:30898-30899.
    PubMed    


  440. YANG C, Liu E, Liu M
    Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2020;117:30025-30026.
    PubMed    


  441. XU X, Han M, Li T, Sun W, et al
    Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
    Proc Natl Acad Sci U S A. 2020;117:30027-30028.
    PubMed    


  442. NISHI A, Dewey G, Endo A, Neman S, et al
    Network interventions for managing the COVID-19 pandemic and sustaining economy.
    Proc Natl Acad Sci U S A. 2020;117:30285-30294.
    PubMed     Abstract available


  443. CASADEVALL A, Pirofski LA
    In fatal COVID-19, the immune response can control the virus but kill the patient.
    Proc Natl Acad Sci U S A. 2020;117:30009-30011.
    PubMed    


  444. KORTESSIS N, Simon MW, Barfield M, Glass GE, et al
    The interplay of movement and spatiotemporal variation in transmission degrades pandemic control.
    Proc Natl Acad Sci U S A. 2020;117:30104-30106.
    PubMed     Abstract available


  445. BAKER RE, Park SW, Yang W, Vecchi GA, et al
    The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.
    Proc Natl Acad Sci U S A. 2020;117:30547-30553.
    PubMed     Abstract available


  446. BANG A, Khadakkar S
    Opinion: Biodiversity conservation during a global crisis: Consequences and the way forward.
    Proc Natl Acad Sci U S A. 2020;117:29995-29999.
    PubMed    


    November 2020
  447. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    PubMed     Abstract available


  448. SRIRAM K, Loomba R, Insel PA
    Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
    Proc Natl Acad Sci U S A. 2020;117:29274-29282.
    PubMed     Abstract available


  449. RELMAN DA
    Opinion: To stop the next pandemic, we need to unravel the origins of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:29246-29248.
    PubMed    


  450. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    PubMed     Abstract available


  451. STOKES GL, Lynch AJ, Lowe BS, Funge-Smith S, et al
    COVID-19 pandemic impacts on global inland fisheries.
    Proc Natl Acad Sci U S A. 2020;117:29419-29421.
    PubMed     Abstract available


  452. WONG F, Collins JJ
    Evidence that coronavirus superspreading is fat-tailed.
    Proc Natl Acad Sci U S A. 2020;117:29416-29418.
    PubMed     Abstract available


  453. SENDER V, Hentrich K, Pathak A, Tan Qian Ler A, et al
    Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways.
    Proc Natl Acad Sci U S A. 2020 Nov 23. pii: 2012265117.
    PubMed     Abstract available


  454. WESTON S, Baracco L, Keller C, Matthews K, et al
    The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
    Proc Natl Acad Sci U S A. 2020 Nov 12. pii: 2012939117.
    PubMed     Abstract available


  455. MIORIN L, Kehrer T, Sanchez-Aparicio MT, Zhang K, et al
    SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Proc Natl Acad Sci U S A. 2020;117:28344-28354.
    PubMed     Abstract available


  456. SEITZ BM, Aktipis A, Buss DM, Alcock J, et al
    The pandemic exposes human nature: 10 evolutionary insights.
    Proc Natl Acad Sci U S A. 2020;117:27767-27776.
    PubMed     Abstract available


  457. LUMENG JC, Chavous TM, Lok AS, Sen S, et al
    Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:27749-27753.
    PubMed    


  458. POLYAKOVA M, Kocks G, Udalova V, Finkelstein A, et al
    Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impacts.
    Proc Natl Acad Sci U S A. 2020;117:27934-27939.
    PubMed     Abstract available


  459. WU M, Chen Y, Xia H, Wang C, et al
    Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
    Proc Natl Acad Sci U S A. 2020;117:28336-28343.
    PubMed     Abstract available


  460. DOLGIN E
    Core Concept: The pandemic is prompting widespread use-and misuse-of real-world data.
    Proc Natl Acad Sci U S A. 2020;117:27754-27758.
    PubMed    


  461. XIONG C, Hu S, Yang M, Luo W, et al
    Mobile device data reveal the dynamics in a positive relationship between human mobility and COVID-19 infections.
    Proc Natl Acad Sci U S A. 2020;117:27087-27089.
    PubMed     Abstract available


  462. GALASSO V, Pons V, Profeta P, Becher M, et al
    Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries.
    Proc Natl Acad Sci U S A. 2020;117:27285-27291.
    PubMed     Abstract available


  463. MEROW C, Urban MC
    Seasonality and uncertainty in global COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2020;117:27456-27464.
    PubMed     Abstract available


  464. LI Z, Li X, Huang YY, Wu Y, et al
    Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
    Proc Natl Acad Sci U S A. 2020;117:27381-27387.
    PubMed     Abstract available


  465. WITTEVEEN D, Velthorst E
    Economic hardship and mental health complaints during COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:27277-27284.
    PubMed     Abstract available


  466. RAO L, Xia S, Xu W, Tian R, et al
    Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.
    Proc Natl Acad Sci U S A. 2020;117:27141-27147.
    PubMed     Abstract available


  467. KAMPF G
    Protective effect of mandatory face masks in the public-relevant variables with likely impact on outcome were not considered.
    Proc Natl Acad Sci U S A. 2020;117:27076-27077.
    PubMed    


  468. NG QX, De Deyn MLZQ, Yeo WS
    Do face masks help? is not the question.
    Proc Natl Acad Sci U S A. 2020;117:27078-27079.
    PubMed    


    October 2020
  469. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.
    PubMed    


  470. SORG RA, Gallay C, Van Maele L, Sirard JC, et al
    Synthetic gene-regulatory networks in the opportunistic human pathogen Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2020 Oct 21. pii: 1920015117.
    PubMed     Abstract available


  471. DOWD JB, Block P, Rotondi V, Mills MC, et al
    Dangerous to claim "no clear association" between intergenerational relationships and COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:25975-25976.
    PubMed    


  472. ARPINO B, Bordone V, Pasqualini M
    Reply to Dowd et al.: Dangerous to overemphasize the importance of specific COVID-19 risk factors based on (unadjusted) macro-level analyses.
    Proc Natl Acad Sci U S A. 2020;117:25977-25978.
    PubMed    


  473. CASTRO M, Ares S, Cuesta JA, Manrubia S, et al
    The turning point and end of an expanding epidemic cannot be precisely forecast.
    Proc Natl Acad Sci U S A. 2020;117:26190-26196.
    PubMed     Abstract available


  474. MCDERMOTT A
    Inner Workings: Researchers race to develop in-home testing for COVID-19, a potential game changer.
    Proc Natl Acad Sci U S A. 2020;117:25956-25959.
    PubMed    


  475. BOSCO-LAUTH AM, Hartwig AE, Porter SM, Gordy PW, et al
    Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats.
    Proc Natl Acad Sci U S A. 2020;117:26382-26388.
    PubMed     Abstract available


  476. LI R, Chen B, Zhang T, Ren Z, et al
    Global COVID-19 pandemic demands joint interventions for the suppression of future waves.
    Proc Natl Acad Sci U S A. 2020;117:26151-26157.
    PubMed     Abstract available


  477. CHENG MH, Zhang S, Porritt RA, Noval Rivas M, et al
    Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Proc Natl Acad Sci U S A. 2020;117:25254-25262.
    PubMed     Abstract available


  478. ABKARIAN M, Mendez S, Xue N, Yang F, et al
    Speech can produce jet-like transport relevant to asymptomatic spreading of virus.
    Proc Natl Acad Sci U S A. 2020;117:25237-25245.
    PubMed     Abstract available


  479. YAM KC, Jackson JC, Barnes CM, Lau J, et al
    The rise of COVID-19 cases is associated with support for world leaders.
    Proc Natl Acad Sci U S A. 2020;117:25429-25433.
    PubMed     Abstract available


  480. NETZ RR, Eaton WA
    Physics of virus transmission by speaking droplets.
    Proc Natl Acad Sci U S A. 2020;117:25209-25211.
    PubMed     Abstract available


  481. WILDER B, Charpignon M, Killian JA, Ou HC, et al
    Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.
    Proc Natl Acad Sci U S A. 2020;117:25904-25910.
    PubMed     Abstract available


  482. BRETT TS, Rohani P
    Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
    Proc Natl Acad Sci U S A. 2020;117:25897-25903.
    PubMed     Abstract available


  483. RAKER EJ, Zacher M, Lowe SR
    Reply to Ng et al.: Not all trauma is the same, but lessons can be drawn from commonalities.
    Proc Natl Acad Sci U S A. 2020;117:25201-25202.
    PubMed    


  484. NG QX, Lim DY, Chee KT
    Not all trauma is the same.
    Proc Natl Acad Sci U S A. 2020;117:25200.
    PubMed    


  485. HEINDEL DW, Koppolu S, Zhang Y, Kasper B, et al
    Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity.
    Proc Natl Acad Sci U S A. 2020 Oct 12. pii: 2008203117.
    PubMed     Abstract available


  486. LOCKHART M, Hill SJ, Merolla J, Romero M, et al
    America's electorate is increasingly polarized along partisan lines about voting by mail during the COVID-19 crisis.
    Proc Natl Acad Sci U S A. 2020;117:24640-24642.
    PubMed     Abstract available


  487. HOLLAND KJ, Cortina LM, Magley VJ, Baker AL, et al
    Don't let COVID-19 disrupt campus climate surveys of sexual harassment.
    Proc Natl Acad Sci U S A. 2020;117:24606-24608.
    PubMed    


  488. SEGALES J, Puig M, Rodon J, Avila-Nieto C, et al
    Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
    Proc Natl Acad Sci U S A. 2020;117:24790-24793.
    PubMed     Abstract available


  489. HOLTER JC, Pischke SE, de Boer E, Lind A, et al
    Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
    Proc Natl Acad Sci U S A. 2020;117:25018-25025.
    PubMed     Abstract available


  490. STEINMAN JB, Lum FM, Ho PP, Kaminski N, et al
    Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics.
    Proc Natl Acad Sci U S A. 2020;117:24620-24626.
    PubMed     Abstract available


    September 2020
  491. ARORA VM, Wray CM, O'Glasser AY, Shapiro M, et al
    Using the curriculum vitae to promote gender equity during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:24032.
    PubMed    


  492. GROSSMAN G, Kim S, Rexer JM, Thirumurthy H, et al
    Political partisanship influences behavioral responses to governors' recommendations for COVID-19 prevention in the United States.
    Proc Natl Acad Sci U S A. 2020;117:24144-24153.
    PubMed     Abstract available


  493. THOMAS LJ, Huang P, Yin F, Luo XI, et al
    Spatial heterogeneity can lead to substantial local variations in COVID-19 timing and severity.
    Proc Natl Acad Sci U S A. 2020;117:24180-24187.
    PubMed     Abstract available


  494. HABEL JR, Nguyen THO, van de Sandt CE, Juno JA, et al
    Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype.
    Proc Natl Acad Sci U S A. 2020;117:24384-24391.
    PubMed     Abstract available


  495. RABE BA, Cepko C
    SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification.
    Proc Natl Acad Sci U S A. 2020;117:24450-24458.
    PubMed     Abstract available


  496. KARATAYEV VA, Anand M, Bauch CT
    Local lockdowns outperform global lockdown on the far side of the COVID-19 epidemic curve.
    Proc Natl Acad Sci U S A. 2020;117:24575-24580.
    PubMed     Abstract available


  497. LINDESTAM ARLEHAMN CS, Sette A, Peters B
    Lack of evidence for BCG vaccine protection from severe COVID-19.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2016733117.
    PubMed    


  498. PATELLA V, Delfino G, Bruzzese D, Giuliano A, et al
    The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2015234117.
    PubMed    


  499. BARILLAS-MURY C, Escobar LE, Molina-Cruz A
    Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guerin (BCG) vaccination on COVID-19 prevalence and mortality.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2017197117.
    PubMed    


  500. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
    Reply to Arora et al.: Concerns and considerations about using the CV as an equity tool.
    Proc Natl Acad Sci U S A. 2020;117:24033-24034.
    PubMed    


  501. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    PubMed    


  502. GANGULI A, Mostafa A, Berger J, Aydin MY, et al
    Rapid isothermal amplification and portable detection system for SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020;117:22727-22735.
    PubMed     Abstract available


  503. THURNER S, Klimek P, Hanel R
    A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2020;117:22684-22689.
    PubMed     Abstract available


    August 2020
  504. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
    A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: